Letter from the Department of Health re. maximising the cost effectiveness of investment in hepatitis C medicines - May 2018
Hepatitis Australia received a letter from the Health Protection Policy Branch responding to our letter encouraging the Australian Government to maximise the cost-effectiveness of it's investment in hepatitis C medicines and supporting primary care to deliver the cures for hepatitis C to people living with hepatitis C.
Leading the way to the elimination of hepatitis C: 2018-2019 pre-budget submission
Prepared in November 2017, the Hepatitis Australia Budget Submission explains why it is so crucial to boost hep C treatments over the next three years and the central roles played by primary care, e-health and community awareness to achieve this short term goal leading to the elimination of hepatitis C as a public health threat by 2030.
No elimination without decriminalization! - Declaration of the Hepatitis Community
Released at the World Hepatitis Summit 2017 Hepatitis Australia has declared its support of this declaration.
"We, members and representatives of the viral hepatitis community—a community that includes people living with viral hepatitis, doctors, nurses, social workers, researchers, public health experts, and people who use drugs—are concerned over the growing gap between the enormous impact of hepatitis B and hepatitis C over people who use drugs and their almost non-existent access to prevention, diagnosis and treatment services around the world."
Download a copy of the full declaration. (PDF 1Mb)